首页 > 最新文献

Current Opinion in Obstetrics & Gynecology最新文献

英文 中文
An update on surgical management for stress urinary incontinence. 压力性尿失禁手术治疗的最新进展。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-07 DOI: 10.1097/GCO.0000000000000989
Kelsey Gallo, Hillary Weiner, Kavita Mishra

Purpose of review: Stress urinary incontinence (SUI) is a common condition for which women often opt for surgical management. Synthetic midurethral slings (MUS) have been the dominant treatment for decades. Single-incision slings (SIS) have been introduced to lower the morbidity associated with trocar passage during MUS placement. Urethral bulking has been used less frequently owing to its lower cure rates. New data have recently emerged in support of single-incision slings (SIS) and urethral bulking with Bulkamid polyacrylamide hydrogel (PAHG).

Recent findings: Several studies with a follow-up ≥10 years have shown stable efficacy and complication rates of retropubic (RMUS) and transobturator (TMUS) midurethral slings over time. SIS products show equivalent efficacy to traditional TMUS and RMUS at up to 3 years of follow-up and can be placed under local anesthesia. While urethral bulking with PAHG results in lower cure rates compared to slings, satisfaction rates are high and responders have sustained improvement at 7 years follow-up.

Summary: All three types of available slings, TMUS, RMUS, and SIS, are now considered appropriate surgical options for the treatment of SUI. Although the absence of comparative data precludes a formal recommendation for one injectable over another, urethral bulking with PAHG has favorable long-term results and an excellent safety profile.

审查目的:压力性尿失禁(SUI)是一种常见疾病,女性通常会选择手术治疗。几十年来,合成尿道中段吊带(MUS)一直是主要的治疗方法。单切口吊带(SIS)的出现降低了在放置尿道中段吊带时与套管通过相关的发病率。尿道膨出术由于治愈率较低而较少使用。最近出现了支持单切口吊带(SIS)和使用 Bulkamid 聚丙烯酰胺水凝胶(PAHG)进行尿道膨出的新数据:一些随访时间≥10 年的研究表明,随着时间的推移,耻骨后(RMUS)和经尿道(TMUS)尿道中段吊带的疗效和并发症发生率趋于稳定。SIS 产品在长达 3 年的随访中显示出与传统 TMUS 和 RMUS 相当的疗效,并且可以在局部麻醉下放置。与吊带相比,使用 PAHG 进行尿道膨出的治愈率较低,但满意率很高,随访 7 年后,有反应者的情况会得到持续改善。摘要:TMUS、RMUS 和 SIS 这三种可用的吊带目前都被认为是治疗 SUI 的合适手术选择。虽然由于缺乏比较数据,不能正式推荐使用哪种注射剂,但使用 PAHG 进行尿道膨出具有良好的长期效果和出色的安全性。
{"title":"An update on surgical management for stress urinary incontinence.","authors":"Kelsey Gallo, Hillary Weiner, Kavita Mishra","doi":"10.1097/GCO.0000000000000989","DOIUrl":"10.1097/GCO.0000000000000989","url":null,"abstract":"<p><strong>Purpose of review: </strong>Stress urinary incontinence (SUI) is a common condition for which women often opt for surgical management. Synthetic midurethral slings (MUS) have been the dominant treatment for decades. Single-incision slings (SIS) have been introduced to lower the morbidity associated with trocar passage during MUS placement. Urethral bulking has been used less frequently owing to its lower cure rates. New data have recently emerged in support of single-incision slings (SIS) and urethral bulking with Bulkamid polyacrylamide hydrogel (PAHG).</p><p><strong>Recent findings: </strong>Several studies with a follow-up ≥10 years have shown stable efficacy and complication rates of retropubic (RMUS) and transobturator (TMUS) midurethral slings over time. SIS products show equivalent efficacy to traditional TMUS and RMUS at up to 3 years of follow-up and can be placed under local anesthesia. While urethral bulking with PAHG results in lower cure rates compared to slings, satisfaction rates are high and responders have sustained improvement at 7 years follow-up.</p><p><strong>Summary: </strong>All three types of available slings, TMUS, RMUS, and SIS, are now considered appropriate surgical options for the treatment of SUI. Although the absence of comparative data precludes a formal recommendation for one injectable over another, urethral bulking with PAHG has favorable long-term results and an excellent safety profile.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"433-438"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion in entertainment media, 2019-2024. 2019-2024 年娱乐媒体中的堕胎问题。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-19 DOI: 10.1097/GCO.0000000000000977
Stephanie Herold

Purpose of review: Entertainment media contribute to how people understand and make sense of health issues, especially stigmatized ones such as abortion. This paper reviews the peer-reviewed literature published between 2019 and 2024 on how abortion is depicted in scripted television and film available for viewing in the United States.

Recent findings: The majority of recent studies focus on qualitative content analysis of a composite of television shows, documenting the myriad ways that these programs reflect and are distinct from the reality of abortion access in the United States. The quantitative studies find small but significant increases in abortion knowledge related to exposure to television abortion plotlines, but no increases in support for abortion postexposure. No studies track the impact of exposure to multiple abortion plotlines at multiple points in time. Only one study included a sample of entertainment content creators to understand their motivations for creating abortion plotlines.

Summary: Media depictions of abortion are often rife with misinformation, and may influence the U.S. public's general knowledge and beliefs about abortion. More research is needed to understand possible relationships between television and film abortion content and its impact on viewers.

审查目的:娱乐媒体有助于人们理解和认识健康问题,尤其是堕胎等被污名化的问题。本文回顾了 2019 年至 2024 年间发表的同行评审文献,内容涉及在美国可供观看的电视电影剧本中如何描述堕胎:最近的大多数研究侧重于对电视节目的综合内容进行定性分析,记录了这些节目反映并区别于美国堕胎现实的各种方式。定量研究发现,与接触电视堕胎情节相关的堕胎知识虽有小幅但显著的增加,但接触后对堕胎的支持却没有增加。没有研究追踪在多个时间点接触多个堕胎情节的影响。只有一项研究对娱乐内容创作者进行了抽样调查,以了解他们创作堕胎情节的动机。摘要:媒体对堕胎的描述往往充斥着错误信息,可能会影响美国公众对堕胎的一般认识和信念。需要进行更多的研究,以了解电视和电影中的堕胎内容与其对观众的影响之间可能存在的关系。
{"title":"Abortion in entertainment media, 2019-2024.","authors":"Stephanie Herold","doi":"10.1097/GCO.0000000000000977","DOIUrl":"10.1097/GCO.0000000000000977","url":null,"abstract":"<p><strong>Purpose of review: </strong>Entertainment media contribute to how people understand and make sense of health issues, especially stigmatized ones such as abortion. This paper reviews the peer-reviewed literature published between 2019 and 2024 on how abortion is depicted in scripted television and film available for viewing in the United States.</p><p><strong>Recent findings: </strong>The majority of recent studies focus on qualitative content analysis of a composite of television shows, documenting the myriad ways that these programs reflect and are distinct from the reality of abortion access in the United States. The quantitative studies find small but significant increases in abortion knowledge related to exposure to television abortion plotlines, but no increases in support for abortion postexposure. No studies track the impact of exposure to multiple abortion plotlines at multiple points in time. Only one study included a sample of entertainment content creators to understand their motivations for creating abortion plotlines.</p><p><strong>Summary: </strong>Media depictions of abortion are often rife with misinformation, and may influence the U.S. public's general knowledge and beliefs about abortion. More research is needed to understand possible relationships between television and film abortion content and its impact on viewers.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"400-407"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adolescent reproductive health in a post- Dobbs landscape: a review. 后多布斯时代的青少年生殖健康:综述。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-07-24 DOI: 10.1097/GCO.0000000000000980
Alexis A Doyle, Serena M Liu, Nichole A Tyson

Purpose of review: To summarize notable recent research in adolescent reproductive health, particularly with respect to a rapidly changing legal landscape surrounding health services that significantly impact adolescent health.

Recent findings: Approval of the first over-the-counter contraceptive pill represented a major advance in adolescent reproductive health, which relied on research regarding its safety, efficacy, and potential to increase access for vulnerable groups. Despite this approval, disparities persist in equitable contraceptive access for adolescents of color and those from sexual and gender identity minorities. Legal changes in access to abortion care and parental involvement in reproductive health decision-making have presented significant challenges for young people across the U.S. Recent research points to the promise of telehealth abortion care and parental acceptance of confidentiality in adolescent reproductive healthcare. Misinformation remains a barrier to advancing adolescent reproductive health and points to continued opportunities for providers to create evidence-based online content.

Summary: In this review, we discuss recent research regarding adolescent reproductive health and laws impacting the reproductive health of adolescents. As the legal landscape evolves, further research surrounding the effect of policy changes that both expand and restrict access to adolescent reproductive health services will be critical to advancing adolescent health.

综述的目的:总结近期在青少年生殖健康方面值得关注的研究,特别是围绕着对青少年健康有重大影响的医疗服务而迅速变化的法律环境:第一颗非处方避孕药的批准是青少年生殖健康领域的一大进步,这有赖于对其安全性、有效性以及增加弱势群体获得避孕药的可能性的研究。尽管获得了批准,但有色人种青少年以及在性取向和性别认同上属于少数群体的青少年在公平获得避孕药具方面仍然存在差距。在获得人工流产护理和父母参与生殖健康决策方面的法律变化给全美青少年带来了重大挑战。最近的研究表明,远程医疗人工流产护理和父母接受青少年生殖保健保密性是大有可为的。错误的信息仍然是促进青少年生殖健康的障碍,这也为医疗服务提供者创建基于证据的在线内容提供了持续的机会。摘要:在这篇综述中,我们讨论了有关青少年生殖健康的最新研究以及影响青少年生殖健康的法律。随着法律环境的不断变化,围绕扩大和限制青少年生殖健康服务的政策变化所产生的影响开展进一步研究,对于促进青少年健康至关重要。
{"title":"Adolescent reproductive health in a post- Dobbs landscape: a review.","authors":"Alexis A Doyle, Serena M Liu, Nichole A Tyson","doi":"10.1097/GCO.0000000000000980","DOIUrl":"10.1097/GCO.0000000000000980","url":null,"abstract":"<p><strong>Purpose of review: </strong>To summarize notable recent research in adolescent reproductive health, particularly with respect to a rapidly changing legal landscape surrounding health services that significantly impact adolescent health.</p><p><strong>Recent findings: </strong>Approval of the first over-the-counter contraceptive pill represented a major advance in adolescent reproductive health, which relied on research regarding its safety, efficacy, and potential to increase access for vulnerable groups. Despite this approval, disparities persist in equitable contraceptive access for adolescents of color and those from sexual and gender identity minorities. Legal changes in access to abortion care and parental involvement in reproductive health decision-making have presented significant challenges for young people across the U.S. Recent research points to the promise of telehealth abortion care and parental acceptance of confidentiality in adolescent reproductive healthcare. Misinformation remains a barrier to advancing adolescent reproductive health and points to continued opportunities for providers to create evidence-based online content.</p><p><strong>Summary: </strong>In this review, we discuss recent research regarding adolescent reproductive health and laws impacting the reproductive health of adolescents. As the legal landscape evolves, further research surrounding the effect of policy changes that both expand and restrict access to adolescent reproductive health services will be critical to advancing adolescent health.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"414-419"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial introductions. 编辑介绍。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-31 DOI: 10.1097/GCO.0000000000000994
{"title":"Editorial introductions.","authors":"","doi":"10.1097/GCO.0000000000000994","DOIUrl":"https://doi.org/10.1097/GCO.0000000000000994","url":null,"abstract":"","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"36 6","pages":"v"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of blood loss in second-trimester abortion. 第二胎流产失血的处理。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-09 DOI: 10.1097/GCO.0000000000000991
Simranvir Kaur, Metabel Tori Markwei, Kate A Shaw

Purpose of review: While major complications in second-trimester abortion are rare, blood loss and hemorrhage are among the most common and have the potential for high morbidity. Here, we review the current literature on risk factors, prevention, and treatment of blood loss in second-trimester abortion.

Recent findings: A comprehensive approach to hemorrhage during second-trimester abortions is essential. Understanding hemorrhage risk factors, prevention strategies, and treatment options makes second-trimester abortion safer. Some pharmacologic methods may both prevent and treat excessive blood loss. Mechanical methods are primarily used for treatment. Key risk factors include prior uterine scars, gestational duration, insufficient cervical preparation, high BMI, procedural inexperience, fetal demise, and halogenated anesthetics. Developing evidence-based protocols for and further research into hemorrhage related complications are crucial for improving safety in second-trimester abortion care.

Summary: Prevention of hemorrhage improves outcomes. However data are limited. For treatment, this includes using pharmacological interventions and mechanical methods. Identifying high-risk patients and implementing preprocedural optimization are proactive measures that aid in decreasing the occurrence and severity of blood loss and hemorrhage.

审查目的:虽然第二胎流产的主要并发症很少见,但失血和大出血是最常见的并发症之一,而且有可能导致高发病率。在此,我们回顾了有关第二胎流产失血的风险因素、预防和治疗的现有文献:最新研究结果:在第二胎流产过程中,采取综合方法处理出血问题至关重要。了解出血风险因素、预防策略和治疗方案可使第二胎人工流产更安全。一些药物治疗方法既能预防又能治疗失血过多。机械方法主要用于治疗。主要的风险因素包括先前的子宫疤痕、妊娠时间、宫颈准备不足、高体重指数、手术经验不足、胎儿夭折和卤素麻醉剂。针对出血相关并发症制定循证方案并开展进一步研究,对于提高第二胎人工流产护理的安全性至关重要。但数据有限。在治疗方面,这包括使用药物干预和机械方法。识别高危患者并实施术前优化是有助于降低失血和大出血发生率和严重程度的积极措施。
{"title":"Management of blood loss in second-trimester abortion.","authors":"Simranvir Kaur, Metabel Tori Markwei, Kate A Shaw","doi":"10.1097/GCO.0000000000000991","DOIUrl":"10.1097/GCO.0000000000000991","url":null,"abstract":"<p><strong>Purpose of review: </strong>While major complications in second-trimester abortion are rare, blood loss and hemorrhage are among the most common and have the potential for high morbidity. Here, we review the current literature on risk factors, prevention, and treatment of blood loss in second-trimester abortion.</p><p><strong>Recent findings: </strong>A comprehensive approach to hemorrhage during second-trimester abortions is essential. Understanding hemorrhage risk factors, prevention strategies, and treatment options makes second-trimester abortion safer. Some pharmacologic methods may both prevent and treat excessive blood loss. Mechanical methods are primarily used for treatment. Key risk factors include prior uterine scars, gestational duration, insufficient cervical preparation, high BMI, procedural inexperience, fetal demise, and halogenated anesthetics. Developing evidence-based protocols for and further research into hemorrhage related complications are crucial for improving safety in second-trimester abortion care.</p><p><strong>Summary: </strong>Prevention of hemorrhage improves outcomes. However data are limited. For treatment, this includes using pharmacological interventions and mechanical methods. Identifying high-risk patients and implementing preprocedural optimization are proactive measures that aid in decreasing the occurrence and severity of blood loss and hemorrhage.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"408-413"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waste not want not: the story of surgical trash. 废物利用:手术垃圾的故事。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-09 DOI: 10.1097/GCO.0000000000000992
Noe Woods, Alexandra I Melnyk, Pamela Moalli

Purpose of review: Our escalating reliance on disposable products in the operating room has generated a large amount of waste, cost, and environmental pollution. Heath damages from the pollution caused by the US healthcare industry cause as much harm, as measured by disability-adjusted life years, as total medical errors. Our response to our own environmental impact should be proportional to that harm. Understanding the waste streams we create and the factors that contribute to our large waste generation in the operating room can help us target solutions to our most harmful practices.

Recent findings: Recent studies within the field of medical waste in ObGyn have included a systematic review analyzing most effective practices for waste reduction and environmental life cycle analyses of specific medical procedures.

Summary: Operating room waste includes regulated medical waste, pathologic waste/chemotherapy, sharps, general municipal waste, recycling, linens, and anesthetic gases. The most effective way to reduce the environmental impact from medical waste is to reduce our use of disposable supplies in favor of durable reusable materials. Other important interventions include eliminating 'overage' of unused supplies, optimizing use of anesthetic gas, custom pack scale backs, and proper waste segregation. This review of operative waste is intended to aid healthcare facilities in understanding and addressing their own environmental impact.

审查目的:我们在手术室中对一次性产品的依赖不断升级,造成了大量的浪费、成本和环境污染。根据残疾调整寿命年数来衡量,美国医疗保健行业造成的污染对健康造成的损害与医疗事故造成的损害一样大。我们对自身环境影响的反应应该与这种危害成正比。了解我们产生的废物流以及导致手术室产生大量废物的因素,可以帮助我们有针对性地解决最有害的做法:摘要:手术室废物包括受管制的医疗废物、病理废物/化疗废物、利器、一般城市废物、回收废物、床单和麻醉气体。减少医疗废物对环境影响的最有效方法是减少一次性用品的使用,转而使用耐用的可重复使用材料。其他重要的干预措施包括消除未使用用品的 "超龄 "现象、优化麻醉气体的使用、定制包装缩减和适当的废物分类。这篇关于手术废物的评论旨在帮助医疗机构了解并解决自身对环境的影响。
{"title":"Waste not want not: the story of surgical trash.","authors":"Noe Woods, Alexandra I Melnyk, Pamela Moalli","doi":"10.1097/GCO.0000000000000992","DOIUrl":"10.1097/GCO.0000000000000992","url":null,"abstract":"<p><strong>Purpose of review: </strong>Our escalating reliance on disposable products in the operating room has generated a large amount of waste, cost, and environmental pollution. Heath damages from the pollution caused by the US healthcare industry cause as much harm, as measured by disability-adjusted life years, as total medical errors. Our response to our own environmental impact should be proportional to that harm. Understanding the waste streams we create and the factors that contribute to our large waste generation in the operating room can help us target solutions to our most harmful practices.</p><p><strong>Recent findings: </strong>Recent studies within the field of medical waste in ObGyn have included a systematic review analyzing most effective practices for waste reduction and environmental life cycle analyses of specific medical procedures.</p><p><strong>Summary: </strong>Operating room waste includes regulated medical waste, pathologic waste/chemotherapy, sharps, general municipal waste, recycling, linens, and anesthetic gases. The most effective way to reduce the environmental impact from medical waste is to reduce our use of disposable supplies in favor of durable reusable materials. Other important interventions include eliminating 'overage' of unused supplies, optimizing use of anesthetic gas, custom pack scale backs, and proper waste segregation. This review of operative waste is intended to aid healthcare facilities in understanding and addressing their own environmental impact.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"444-449"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contraception and abortion update: forward gears only. 避孕和堕胎的最新情况:仅向前推进。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-10-31 DOI: 10.1097/GCO.0000000000000993
Paul D Blumenthal
{"title":"Contraception and abortion update: forward gears only.","authors":"Paul D Blumenthal","doi":"10.1097/GCO.0000000000000993","DOIUrl":"10.1097/GCO.0000000000000993","url":null,"abstract":"","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":"36 6","pages":"385-387"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologic grafts for pelvic organ prolapse repairs: what have we learned in the last 20 years? 用于盆腔器官脱垂修复的生物移植物:过去 20 年我们学到了什么?
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-02 DOI: 10.1097/GCO.0000000000000990
Karla Lorente, Olivia Chang

Purpose of review: The ideal graft material for the augmentation of pelvic organ prolapse (POP) has yet to be discovered. While synthetic mesh offers durable repairs this can be at the expense of mesh complications. Biologic grafts have been considered an alternative. This chapter reviews biologic graft materials as applied to POP surgery.

Recent findings: The heterogeneity of available graft materials and definitions of success in POP literature make comparisons difficult. There may be utility in the augmentation of apical prolapse with autologous grafts. There is also modest evidence to support anterior wall augmentation with biologic grafts. However, a 2024 Cochrane review concluded there is not enough evidence to support routine use of grafts for transvaginal repairs.

Summary: Biologic grafts can be considered in certain cases. There continues to be a need for finding the ideal "graft-patient" combination. The field particularly needs more robust research in the recurrent POP patient population.

审查目的:用于增大盆腔器官脱垂(POP)的理想移植物材料尚未找到。虽然合成网片可提供持久的修复效果,但这可能是以网片并发症为代价的。生物移植物一直被认为是一种替代品。本章回顾了应用于 POP 手术的生物移植物材料:现有移植物材料的异质性和 POP 文献中对成功的定义使得比较变得困难。自体移植物可能有助于增大顶端脱垂。也有少量证据支持使用生物移植物增强前壁。然而,2024 年的 Cochrane 综述认为,没有足够的证据支持常规使用移植物进行经阴道修复。目前仍需要找到理想的 "移植物-患者 "组合。该领域尤其需要对复发性 POP 患者进行更深入的研究。
{"title":"Biologic grafts for pelvic organ prolapse repairs: what have we learned in the last 20 years?","authors":"Karla Lorente, Olivia Chang","doi":"10.1097/GCO.0000000000000990","DOIUrl":"10.1097/GCO.0000000000000990","url":null,"abstract":"<p><strong>Purpose of review: </strong>The ideal graft material for the augmentation of pelvic organ prolapse (POP) has yet to be discovered. While synthetic mesh offers durable repairs this can be at the expense of mesh complications. Biologic grafts have been considered an alternative. This chapter reviews biologic graft materials as applied to POP surgery.</p><p><strong>Recent findings: </strong>The heterogeneity of available graft materials and definitions of success in POP literature make comparisons difficult. There may be utility in the augmentation of apical prolapse with autologous grafts. There is also modest evidence to support anterior wall augmentation with biologic grafts. However, a 2024 Cochrane review concluded there is not enough evidence to support routine use of grafts for transvaginal repairs.</p><p><strong>Summary: </strong>Biologic grafts can be considered in certain cases. There continues to be a need for finding the ideal \"graft-patient\" combination. The field particularly needs more robust research in the recurrent POP patient population.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"439-443"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review of ethnic disparities in preeclampsia. 回顾子痫前期的种族差异。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-18 DOI: 10.1097/GCO.0000000000000996
Katie Raphael, Kate Wiles, Stamatina Iliodromiti, Elena Greco

Purpose of review: Recent reports have reiterated the inequities in maternal morbidity and mortality for minority ethnic groups, with preeclampsia being a significant concern. Females of Black and South Asian ethnicity have an increased risk of preeclampsia with disproportionately higher adverse outcomes compared to white females.

Recent findings: This review will explore ethnic disparities in preeclampsia outcomes, prediction, diagnosis, prevention and management. Recent evidence has demonstrated that biochemical and biophysical markers that are used for preeclampsia prediction and diagnosis vary for females of different ethnic groups. This needs careful consideration given the current need for accurate prediction models. Furthermore, recent reports have highlighted the disparity in maternal morbidity for those of minority ethnic groups. The reasons for this are multifactorial but underlying biases and racism have been attributed as major contributors to poor care and adverse outcomes.

Summary: Exploring disparities in preeclampsia care is essential to address ethnic inequities that lead to increased adverse outcomes. We must alter current clinical practice to break down the barriers that result in substandard care for females from minority ethnic backgrounds.

审查目的:最近的报告重申了少数族裔群体在孕产妇发病率和死亡率方面的不平等,其中先兆子痫是一个令人严重关切的问题。与白人女性相比,黑人和南亚女性患先兆子痫的风险更高,不良后果也更严重:本综述将探讨先兆子痫在预后、预测、诊断、预防和管理方面的种族差异。最近的证据表明,用于子痫前期预测和诊断的生化和生物物理标记物对不同种族的女性有差异。鉴于目前需要准确的预测模型,这一点需要仔细考虑。此外,最近的报告强调了少数民族孕产妇发病率的差异。原因是多方面的,但潜在的偏见和种族主义被认为是导致不良护理和不良结局的主要因素。摘要:要解决导致不良结局增加的种族不平等问题,探索子痫前期护理中的差异至关重要。我们必须改变目前的临床实践,打破导致少数族裔女性护理不达标的障碍。
{"title":"A review of ethnic disparities in preeclampsia.","authors":"Katie Raphael, Kate Wiles, Stamatina Iliodromiti, Elena Greco","doi":"10.1097/GCO.0000000000000996","DOIUrl":"10.1097/GCO.0000000000000996","url":null,"abstract":"<p><strong>Purpose of review: </strong>Recent reports have reiterated the inequities in maternal morbidity and mortality for minority ethnic groups, with preeclampsia being a significant concern. Females of Black and South Asian ethnicity have an increased risk of preeclampsia with disproportionately higher adverse outcomes compared to white females.</p><p><strong>Recent findings: </strong>This review will explore ethnic disparities in preeclampsia outcomes, prediction, diagnosis, prevention and management. Recent evidence has demonstrated that biochemical and biophysical markers that are used for preeclampsia prediction and diagnosis vary for females of different ethnic groups. This needs careful consideration given the current need for accurate prediction models. Furthermore, recent reports have highlighted the disparity in maternal morbidity for those of minority ethnic groups. The reasons for this are multifactorial but underlying biases and racism have been attributed as major contributors to poor care and adverse outcomes.</p><p><strong>Summary: </strong>Exploring disparities in preeclampsia care is essential to address ethnic inequities that lead to increased adverse outcomes. We must alter current clinical practice to break down the barriers that result in substandard care for females from minority ethnic backgrounds.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"450-456"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rh sensitization in abortion care: where we've been and where we're going. 人工流产护理中的 Rh 敏感性:我们的过去和未来。
IF 2.2 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2024-12-01 Epub Date: 2024-09-12 DOI: 10.1097/GCO.0000000000000988
Stephanie I Amaya, Erica Cahill, Paul D Blumenthal

Purpose of review: The purpose of this review is to summarize the historical context and recent literature that contribute to the debate about preventive strategies for Rhesus (Rh)-alloimmunization in abortion are.

Recent findings: Recent studies repeatedly demonstrate that the risk of Rh-alloimmunization in first trimester abortion care is very low.

Summary: Recent high-quality studies have demonstrated the physiologic presence of fetal red blood cells in maternal circulation even prior to abortion. Thus, establishing the low utility of Rh immunoglobulin prior to abortion before 12 weeks of gestation. There is yet to exist a consensus guideline that balances the desire to prevent a rare devastating outcome and the need to create practical guidelines based on evidence-based risk assessments.

综述的目的:本综述旨在总结历史背景和最新文献,这些文献有助于就人工流产中的Rh-高免 疫预防策略展开讨论:最近的研究反复证明,妊娠头三个月人工流产护理中的Rh-高免风险非常低:最近的高质量研究表明,即使在人工流产前,母体血液循环中也存在胎儿红细胞。因此,在妊娠 12 周前进行人工流产前注射 Rh 免疫球蛋白的效用很低。目前还没有一个共识性的指导原则,既要防止罕见的破坏性结果,又要根据循证风险评估制定实用的指导原则。
{"title":"Rh sensitization in abortion care: where we've been and where we're going.","authors":"Stephanie I Amaya, Erica Cahill, Paul D Blumenthal","doi":"10.1097/GCO.0000000000000988","DOIUrl":"10.1097/GCO.0000000000000988","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to summarize the historical context and recent literature that contribute to the debate about preventive strategies for Rhesus (Rh)-alloimmunization in abortion are.</p><p><strong>Recent findings: </strong>Recent studies repeatedly demonstrate that the risk of Rh-alloimmunization in first trimester abortion care is very low.</p><p><strong>Summary: </strong>Recent high-quality studies have demonstrated the physiologic presence of fetal red blood cells in maternal circulation even prior to abortion. Thus, establishing the low utility of Rh immunoglobulin prior to abortion before 12 weeks of gestation. There is yet to exist a consensus guideline that balances the desire to prevent a rare devastating outcome and the need to create practical guidelines based on evidence-based risk assessments.</p>","PeriodicalId":55194,"journal":{"name":"Current Opinion in Obstetrics & Gynecology","volume":" ","pages":"394-399"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Obstetrics & Gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1